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Afrouz Abbaspour1, Nicole Reichardt4, Yoshiaki Fujii-Kuriyama5, Joseph Rafter6, Arjan Narbad4, Elaine Holmes2, Jeremy Nicholson2,
Velmurugesan Arulampalam1 and Sven Pettersson1,7,8
The ligand-induced transcription factor, aryl hydrocarbon receptor (AhR) is known for its capacity to tune adaptive immunity and
xenobiotic metabolism—biological properties subject to regulation by the indigenous microbiome. The objective of this study was
to probe the postulated microbiome-AhR crosstalk and whether such an axis could inﬂuence metabolic homeostasis of the host.
Utilising a systems-biology approach combining in-depth 1H-NMR-based metabonomics (plasma, liver and skeletal muscle) with
microbiome proﬁling (small intestine, colon and faeces) of AhR knockout (AhR− /−) and wild-type (AhR+/+) mice, we assessed AhR
function in host metabolism. Microbiome metabolites such as short-chain fatty acids were found to regulate AhR and its target
genes in liver and intestine. The AhR signalling pathway, in turn, was able to inﬂuence microbiome composition in the small
intestine as evident from microbiota proﬁling of the AhR+/+ and AhR− /− mice fed with diet enriched with a speciﬁc AhR ligand or
diet depleted of any known AhR ligands. The AhR− /− mice also displayed increased levels of corticosterol and alanine in serum.
In addition, activation of gluconeogenic genes in the AhR− /− mice was indicative of on-going metabolic stress. Reduced levels of
ketone bodies and reduced expression of genes involved in fatty acid metabolism in the liver further underscored this observation.
Interestingly, exposing AhR− /− mice to a high-fat diet showed resilience to glucose intolerance. Our data suggest the existence of a
bidirectional AhR-microbiome axis, which inﬂuences host metabolic pathways.
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INTRODUCTION
The mammalian body is a mosaic of different microorganisms and
eukaryotic cells which share a set of biological and biochemical
needs important for growth, body physiology, survival and
reproduction (reviewed in reference 1). The gut microbiota, in
addition to their ability to process dietary derived material, also
inﬂuences host responses to xenobiotics,2 adding to the growing
consensus that factors involved in xenobiotic metabolism could
be in intimate partnership with the microbial world. The aryl
hydrocarbon receptor (AhR) is a xenobiotic sensor and, belongs to
the basic helix–loop–helix Per–Arnt–Sim family and regulates
phase I drug-metabolising enzymes from the cytochrome p450
family: Cyp1a1, Cyp1a2 and Cyp1b1.3 Apart from well-known
man-made pollutants (e.g., 2,3,7,8-tetrachlorodibenzo-p-dioxin),4
a battery of natural AhR ligands have been discovered. These
include kynurenine and planar indoles made during metabolism
of tryptophan,5,6 such as indole-3-carbinol, which is present in
broccoli and cauliﬂower.7,8 AhR is also known to be an important
regulator of metabolic and immune processes, both of which are
vital for intestinal homeostasis, as well as for optimal coexistence
of the host and its microbiome. Ligand-dependent activation of
AhR has been shown to abrogate colitis, a disease linked to
changes of the gut microbiome homeostasis.7,9 More recently,
bacterially derived molecules such as phenazines and indole
derivates have been shown to work as AhR activators,9,10
which implies the existence of a possible microbiome-AhR
communication. In this study, host metabolic homeostasis and
health has been explored within the context of gut microbiome’s
inﬂuence on AhR functions.
RESULTS
Gut microbiome inﬂuence AhR function
In the ﬁrst set of experiments we assessed whether the
microbiome or its metabolites could inﬂuence AhR function.
We compared AhR function in livers of mice carrying a normal
bacterial ﬂora (speciﬁc pathogen-free, SPF) and that from germ-
free (GF) mice. Expression of AhR along with the AhR target genes
Cyp1a1 and aryl hydrocarbon receptor repressor (AhRR) was
higher in the liver of SPF mice than in those of GF mice (Figure 1a).
Indoleamine-2,3-dioxygenase (Ido) proteins are key enzymes that
control the metabolism of tryptophan to kynurenine, which is a
low-afﬁnity ligand for AhR.6 The expression of Ido1 was also
induced in the presence of bacterial ﬂora (Figure 1a). The
expression of Cyp1a2, and Cyp1b1 though remained unaltered.
Short-chain fatty acids (SCFAs), including acetate, propionate and
butyrate, are derived through microbiota-driven anaerobic fer-
mentation and are used as an energy source for some cell types,
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such as colonocytes. Nutrients absorbed from the intestine,
including SCFA, are transported to the liver through the
enterohepatic circulation and thus can inﬂuence metabolic
processes in the liver and affect host health. We then assessed
how hepatic tissue responded to selected bacterial metabolites.
Administration of butyrate to GF mice marginally induced the
expression of AhR and AhRR. The AhR target genes Cyp1a2 and
Cyp1b1, however, responded robustly (Figure 1b).
Furthermore, we conﬁrmed that bacterial signals regulate AhR
activity in the intestine as well. We observed signiﬁcant elevation
of Cyp1a1 and AhRR in the intestinal epithelial cells (IECs) of SPF
mice than in those of GF mice (Figure 1c). Administration of
butyrate to GF mice induced the expression of the AhRR and
Cyp1a1, similarly to the effect observed in the presence of whole
bacterial ﬂora (SPF mice; Figure 1d). We also used an in vitro
system where HT-29 cells were treated with the most prevalent
Figure 1. Bacteria and butyrate regulate the expression of AhR and its target genes. (a, b) Quantitative RT-PCR results depict the expression of
Cyp1a1, Cyp1a2, Cyp1b1, AhRR, AhR and Ido1 in liver tissue from (a) germ-free (GF) and speciﬁc pathogen-free (SPF) mice (n= 5 mice per group),
and (b) GF mice gavaged with water or butyrate (1 g/kg body weight; n= 5 mice per group). Quantitative RT-PCR results regarding the
expression of Cyp1a1, Cyp1a2, Cyp1b1, AhRR and AhR in epithelial scrapings from the distal small intestine of (c) germ-free (GF) mice and
speciﬁc pathogen-free (SPF) mice (n= 5 mice per group) and (d) GF mice gavaged with water or butyrate (1 g/kg body weight; n= 5
mice/group). *Po0.05, **Po0.01 (Student’s t-test). (e) Quantitative RT-PCR results demonstrate the effects of AhR knockdown by siRNA
(siAhR) on AhR and (f) Cyp1a1 mRNA expression in HT-29 cells. Cells were transfected with Silencer Select siRNA products directed against AhR
(siAhR) or Silencer Select Negative Control #2 siRNA (scrambled). Cells were treated with butyrate (NaB, 2 mmol/l) for 24 h. Control cells (NT)
were treated with RPMI medium only. Experiments were performed twice, with biological triplicates, per treatment and per experiment and
technical triplicates of each sample for qPCR. Bars and error bars depict the mean± s.e.m. (a–d) or mean± s.d. (e, f). Genes of interest were
normalised to Hprt (a), and 18SrRNA (b) and to β-actin (c–f). *Po0.05, ***Po0.001 against GF controls (Student’s t-test). *Po0.05, **Po0.01
between indicated bars (two-way analysis of variance (ANOVA)). RT-PCR, reverse transcription PCR.
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bacterial metabolites, such as acetate, propionate and butyrate
(Supplementary Figure 1). Only butyrate was able to induce
the expression of both AhR and its target gene Cyp1a1
(Supplementary Figure 1a,b). Propionate could induce AhR
expression only, whereas, administration of acetate had no
signiﬁcant effects on the gene expression levels of Cyp1a1 and
AhR (Supplementary Figure 1a,b) indicating butyrate to be more
efﬁcient to inﬂuence AhR activity. To test further whether the
effect of butyrate on intestinal epithelial cells is AhR-dependent,
we blocked the activity of AhR in HT-29 cells using AhR siRNA
(Figure 1e). Butyrate-induced expression of Cyp1a1 was reduced
in siRNA treated group, suggesting that butyrate activates the
expression of Cyp1a1 in AhR-dependent manner (Figure 1f). These
observations demonstrate that the gut microbiome can activate
AhR. Previously, the commensal bacterial strain, Lactobacillus
bulgaricus OLL1181, has been shown to induce Cyp1a1 expression
in IECs in vitro and in vivo11 further consolidating observations that
indigenous bacteria might inﬂuence AhR activity. Moreover,
microbial metabolites such as the SCFAs (as observed in our
study) may affect AhR function indirectly by signal transduction
via G-protein-coupled receptors that use SCFA as ligands (GPR41
and GPR43). SCFA may also regulate AhR function through the
inhibition of histone deacetylases.12–14 Another mode of action
maybe through the Toll-like receptor (TLR) signalling, especially
via TLR2.15,16 In response to oral challenge of AhR ligand benzo(a)
pyren, TLR2− /− mice do not show upregulation of the AhR target
gene Cyp1a1 expression.17 Furthermore, metabolites produced by
the microbiome, owing to their similar aromatic structure, could
be considered as endogenous ligands for the AhR, for
example phenazines, which are produced by Enterobacteriacea,
or naphthoquinones, present in a broad range of prokaryotes.18,19
AhR expression inﬂuences the gut microbiome composition
preferentially in the small intestine
Having established a possible microbiome–AhR axis, we next
investigated whether AhR expression could inﬂuence and shape
the intestinal bacterial community. To gain detailed insight into
bacterial composition within different compartments of the
gastrointestinal tract, we collected colonic and small intestinal
contents, as well as faecal samples from AhR knockout (AhR− /−)
and wild-type (AhR+/+) mice for sequencing. AhR is activated by
dietary ligands that are present in standard mouse chow (e.g.,
phenols and tryptophan derivatives). In order to avoid such
confounding effects, the offspring of AhR− /+ crosses were fed a
specially formulated diet depleted of potential AhR ligands (F2
diet) or a F2 diet enriched with a known AhR ligand (DIM diet).7
The faecal, colonic, and small intestinal materials were collected
from AhR− /− and AhR+/+ mice and the composition of bacterial
communities were evaluated and compared using 16S ribosomal
RNA (rRNA) 454 pyrosequencing. We observed differences in the
composition of the microbial communities to the presence or
absence of AhR itself, independently of ligand activation
(Supplementary Table 1, Figure 2). Bacteroidetes, Actinobacteria
and Tenericutes were more prevalent in AhR+/+ mice in
comparison to the AhR− /− mice on F2 diet. Moreover, small
intestines of AhR+/+ mice that received a DIM-enriched diet
exhibited lower prevalence of Bacteroidetes and higher preva-
lence of Firmicutes than mice that received F2 chow. Our ﬁndings
are in accordance with a previous report showing the outgrowth
of bacteria belonging to the Bacteroidetes phylum in the small
intestines of AhR− /− mice.8 This difference in bacterial composi-
tion in the small intestine of AhR+/+ mice fed F2 versus DIM diet,
indicates that the activation of AhR by dietary ligand is able to
Figure 2. The presence of AhR inﬂuences intestinal bacterial composition. The average prevalence of distinct bacterial groups in the small
intestine of AhR+/+ and AhR− /− mice fed F2 or DIM diets, obtained by 454 sequencing platform. The pie charts depict the composition of the
microbiome in the small intestine (n= 4 AhR− /− DIM-fed mice, n= 4 AhR− /− F2-fed mice, n= 5 AhR+/+ DIM-fed mice, and n= 6 AhR+/+
F2-fed mice).
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inﬂuence the composition of intestinal bacteria (Supplementary
Table 1, Figure 2). Signiﬁcant differences were also observed
within the Firmicutes phylum: bacteria belonging to the class
Bacilli were more prevalent in DIM-fed mice, while Clostridia were
more prevalent in F2-fed mice. These differences were not
pronounced when comparing small intestinal bacterial commu-
nities of AhR− /− mice receiving F2 or DIM diets, which emphasises
the speciﬁcity of response to DIM and excludes the possibility that
the food component DIM (which can be treated
as a source of bacterial nutrition) directly affects bacterial
composition in an AhR-independent manner.
We did not, surprisingly, observe any signiﬁcant differences in
the composition of microbiome in the faeces or colon between
the genotypes and diets (Supplementary Tables 2 and 3;
Supplementary Figure 2a,b). These results support the notion of
regional microbiome-tissue communication that was recently
proposed for the crypt region of the intestine.20 In addition, this
data, raise further concerns regarding the conventional way to
proﬁle microbiome status through characterisation of fecal
samples. That the faecal bacterial composition might not be fully
representative of the communities in various anatomical regions
of the gastrointestinal tract has been reported previously.21
The distribution and co-localisation of microbiome communities
are at present completely unknown and studies to further clarify
the prevalence of bacterial phyla, classes, and species within the
stomach, small intestine, and colon are highly warranted.
Altogether, our results suggest that compromise of AhR function,
through genetic modiﬁcation or lack of ligands, leads to changes
in the composition of commensal bacteria within the small
intestine.
AhR regulates energy metabolism
Alterations in gut microbiome inﬂuences host metabolism and
energy homeostasis. To address the role of AhR in the regulation
of energy homeostasis, we measured global changes in metabolic
phenotype between AhR− /− and AhR+/+ mice by generating
metabolic proﬁles of plasma, liver, and skeletal muscle
(Supplementary Figures 3a–c and 4a–c, respectively) using proton
nuclear magnetic resonance spectroscopy (1H NMR). We com-
pared the levels of identiﬁed metabolites in AhR− /− versus AhR+/+
animals and observed signiﬁcant differences in the concentrations
of various metabolites (summarised in Table 1) after a 12 h fasting
period.
Glucose levels in both plasma and liver were found to be lower
in the AhR− /− mice than in AhR+/+ mice, while levels of lactate (the
main product of glycolysis) were elevated in the plasma and the
skeletal muscle of AhR− /− mice. Lactate, together with alanine
acts as important substrate for gluconeogenesis during fasting.
Notably, levels of alanine were lower in AhR− /− muscle and liver.
Increased release of lactate and alanine into blood, as observed in
AhR− /− probably indicate that glucose-utilising peripheral tissues
catabolise glucose and hence allow it to be utilised as
gluconeogenic precursors in the liver undermining the metabolic
switch to gluconeogenesis to provide energy to the system
during fasting. Glycerol is another known substrate for gluconeo-
genesis. Glycerol levels were found to be higher both in the
plasma and liver of AhR− /− mice, indicating that these metabolites
might also be used as substrates for gluconeogenesis.
On the basis of these observations, we queried whether
gluconeogenesis was altered in AhR− /− mice liver by checking
the gene expression level of glucose-6-phosphatase (G6Pase), the
ﬁnal enzyme in the gluconeogenesis pathway in the liver. Indeed,
the level of G6Pase was higher in AhR-deﬁcient mice (Figure 3a)
conﬁrming that gluconeogenesis is induced in AhR− /− mice
probably to maintain blood glucose levels to sustain energy
metabolism of other glucose-dependent tissues in the
fasted state.
Another striking difference was the lower level of ketone bodies
(3-hydroxybutyrate) in the plasma and skeletal muscle of AhR− /−
mice (Table 1). During fasting, ketone bodies are produced as a
product of fatty acid oxidation or metabolism of certain amino
acids. The liver synthesises and releases ketone bodies, primarily
3-hydroxybutyrate, to be used as fuel by peripheral tissues.
Decreased levels of ketone bodies in both plasma and muscle
reﬂect that AhR− /− mice are somehow impaired of utilising fatty
acid oxidation as their source of fuel. This was further evaluated by
observing lower levels of expression of Hmgcs2, the main enzyme
controlling ketone body production (Figure 3b), and of various
genes involved in fatty acid transport and metabolism. Reduced
hepatic Pparα expression level was also observed in AhR− /− mice
compared to AhR+/+ mice (Figure 3c). We subsequently also
observed that the mRNA expression levels of other genes involved
in fatty acid transport and metabolism (Cd36, Fabp1, Acox1, Cpt1a,
Cpt2, Cyp4a1 and Mcad), were generally downregulated in AhR− /−
mice (Figure 3d). Impaired fatty acid oxidation and enhanced
gluconeogenesis indicates that AhR− /− mice might be experien-
cing metabolic stress, which is reﬂected by increased levels of
corticosterol in the blood. Indeed, as expected higher levels of
glucocorticoids in the plasma of AhR− /− mice were observed
(Figure 3e). Elevated levels of glucocorticoids, as well as cellular
stress, is known to accumulate and stabilise p53, a master
regulator known to promote cellular survival under energy
shortage conditions.22–24 Most interestingly, we did observe
elevated levels of p53 protein in the livers of AhR− /−
mice (Figure 3f) further underscoring the metabolic duress in
AhR− /− mice.
In order to understand the metabolic limitations of the
AhR-deﬁcient mice, we challenged these mice with a diet rich in
Table 1. List of metabolites that were found to be different in AhR+/+
and AhR− /− mice (n= 4 mice/group)
Lower in AhR− /− Higher in AhR− /−
Metabolite Correlation
coefﬁcient
Metabolite Correlation
coefﬁcient
Plasma
Methylmalonate 0.8 Tyrosine 0.9
Glucose 0.5 Creatine 0.9
3-Hydroxybutyrate 0.7 Alanine 0.8
Lactate 0.8
Citrate 0.8
TMAO 0.7
Glycerol 0.7
Liver
Inosine 0.8 Creatine 0.9
Choline 0.8 TMAO 0.7
Leucine 0.6 Betaine 0.6
Valine 0.6 Glycerol 0.5
Isoleucine 0.6 Taurine 0.3
Glutamate 0.5 Acetate 0.3
Glucose 0.3
Alanine 0.3
Lactate 0.3
Skeletal muscle
Taurine 0.6 Lactate 0.6
3-hydroxybutyrate 0.7
Alanine 0.8
Isoleucine 0.8
Abbreviation: AhR, aryl hydrocarbon receptor; TMAO, trimethylamine N-
oxide.
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fat. For eleven consecutive weeks, AhR− /− and AhR+/+ mice were
fed a semi-synthetic chow in which 40% of calories are derived
from fat (high-fat diet, HFD). No signiﬁcant differences in weight
gain (Supplementary Figure 5a), chow intake (Supplementary
Figure 5b), or fasting insulin levels (Supplementary Figure 5e) were
observed between the two genotypes. Interestingly, at the basal
condition we observed that the body weight of AhR− /− mice is
signiﬁcantly lower than the AhR+/+ mice (Supplementary
Figure 5c). However, this difference in body weight no longer
exists once the mice were fed HFD for eleven weeks
(Supplementary Figure 5d). A signiﬁcant increase in body weight
was observed in the AhR+/+ and AhR− /− mice after 11 weeks of
HFD treatment in comparison with the respective chow-treated
groups (Supplementary Figure 5d). However, there was no
signiﬁcant difference in the food intake between the AhR+/+ and
AhR− /− mice on chow diet or on HFD (Supplementary Figure 5b).
Surprisingly, we observed that AhR− /− mice exhibited lower
fasting glucose levels (Figure 4a; Table 2) and improved glucose
tolerance (Figure 4b), compared with AhR+/+ mice indicating
partial protection against diet-induced glucose intolerance in
AhR− /− mice. Furthermore, the expression of glucose-6-
phosphatase seemed to be lower though not statistically
signiﬁcant in AhR− /− mice livers compared with AhR+/+ mice
when fed HFD (Figure 4c). This is in striking contrast to our
observations in fasted conditions under normal chow feeding.
Thus higher hepatic glucose levels (Table 2) along with higher
Figure 3. Altered fatty acid and glucose metabolism in AhR− /− mice. Quantitative RT-PCR results regarding the expression of (a) glucose-6-
phosphatase and (b) Hmgcs2 in liver and Pparα (c) and genes involved in lipid metabolism (d) in the livers of AhR− /− and AhR+/+ mice (n= 4
mice/group). (e) Plasma corticosterol levels (measured by ELISA) are higher in AhR− /− mice (n= 4 mice/group). (f) Western blotting (left panel)
showing expression of p53 with quantiﬁcation (right panel) to relative levels of tubulin in the liver of AhR− /− and AhR+/+ mice (n= 4
mice/group). Bars and error bars depict the mean s.e.m. Gene expression for a, b was normalised to 18SrRNA, whereas for c, d normalised to
Hprt. *Po0.05; **Po0.01 against AhR+/+ mice (Student’s t-test).
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gluconeogenic precursors such as alanine and lactate in HFD fed
AhR− /− mice liver reﬂects a possible mode to control and maintain
peripheral glucose levels in response to HF feeding. This might
possibly be due to better glucose disposal to peripheral tissues.
From these observations it is evident that AhR is instrumental in the
dynamic regulation of whole-body glucose homeostasis depending
on nutrient availability and energy demand of
the host. However, metabolic proﬁling of plasma in HFD conditions
revealed similar differences for 3-hydroxybutyrate between AhR− /−
and AhR+/+ mice as were observed for normal chow-fed mice
(summarised in Table 2). Consequently, the expression of Hmgcs2
and Pparα remained lower along with other genes involved in fatty
acid transport and oxidation in livers of AhR− /− mice (Figure 4c)
signifying impaired hepatic lipid metabolism in these mice. HF
feeding also abrogated the differences in the levels of plasma
corticosterol in AhR− /− mice to the level observed in AhR+/+ mice
(Figure 4d) reﬂecting that their modulations are indeed in response
to the metabolic milieu that could be altered as and when energy
demand of the system changes. We also observed high expression
levels of p53 in AhR− /− mice in comparison to AhR+/+ mice when
challenged with HFD (Supplementary Figure 5f), though not
statistically signiﬁcant. The induced p53 is probably a reﬂection of
the metabolic stress these mice encounter, as also observed in
AhR− /− mice in basal condition on chow diet (Figure 3f). Hence, it
seems that the AhR− /− mice is likely at a metabolic advantage
through enhanced gluconeogenesis in liver during fasting to
regulate hypoglycemia. However, with dietary challenge the
AhR− /− mice is probably more efﬁcient in disposal of glucose load
to peripheral tissues as well as restricting gluconeogenesis,
preventing HFD induced glucose intolerance.
DISCUSSION
In the present study, we have identiﬁed a bidirectional
microbiome-AhR axis that inﬂuences host metabolism in the
liver and ketone body production. Our ﬁndings showing that
production of ketone bodies can be regulated by AhR implies an
AhR-dependent feed-forward mechanism to secure nutrients to
the host under conditions of starvation. Our observations also
suggest a novel but less understood role of AhR in the modulation
of gut microbiome composition in the small intestine. Such
changes in the microbiome possibly impart metabolic conse-
quences and may contribute to deregulated energy metabolism.
However, an altered immune system imparting the changes seen
in the microbiota composition of AhR− /− mice cannot be ruled
out. Indeed, the reported elevation of inﬂammation circuits in
AhR− /− mice supports such a mechanism. In a recent study
the ketone metabolite beta-hydroxybutyrate, was shown to
suppress NLRP3-driven inﬂammation under nutritional constrain
conditions.25 Thus, AhR-mediated regulation of ketone body
production illustrates the intricate interplay between inﬂamma-
tion and metabolism where this metabolic product may act as an
immunomodulatory currency.
Most well-known ligands for the AhR, including biphenyls,
phenylalanine hydroxylases, aromatic amines and dioxins, are
lipid-soluble molecules.4 These substances, also known as
persistent organic pollutants, accumulate in the white adipose
tissue and are released from this tissue together with lipids.26
Persistent organic pollutants have endocrine disruptive properties
and can interfere with the activity of many nuclear receptors,
resulting in profound alterations of hormonal balance.27 We
speculate that lack of AhR, one of the main proteins that
orchestrate the breakdown of these dangerous substances,
initiates transcriptional and translational changes in the liver in
order to protect it from the toxic effects of persistent organic
pollutants. Possible protective responses include the downregula-
tion of lipid transport to the liver by decreasing the expression of
Cd36 and Fabp1 and also invoking cellular responses to stress
through the regulation of gluconeogenesis, by increasing hepatic
glucose production and the expression of glucose-6-phosphatase
in the liver.28
Disturbances in glucose and fatty acid metabolism may lead to
serious metabolic problems, including type II diabetes and
obesity-related co-morbidities. Quantitative trait locus analysis of
dietary obesity in C57BL/6 and129P3/J F2 mice revealed that the
AhR gene is one of seven candidate genes associated with
increased body weight.29 Moreover, a shift in the ratio between
Bacteroidetes and Firmicutes in the intestine has been linked with
development of obesity in both mice and humans.30–34 We did
not observe a difference in weight gain between AhR− /− and
AhR+/+ mice on HFD. However, we did observe that the AhR− /−
mice were partially protected against diet-induced glucose
intolerance. Whether this protection is due to their altered
microbiome composition in the small intestine in the AhR− /−
mice remains to be seen. In order to demonstrate cause or
consequence effects, extensive additional experiments will have
to be done, but is beyond the scope of this study.
Our data suggest that bilateral communication links the
microbiome to AhR, an evolutionarily conserved environmental
sensor in many eukaryotes, impacting immune and energy
homeostasis. Dynamic changes in the gut microbiome may confer
metabolic and developmental consequences to the host through
AhR. The current study has established such associations between
microbiome-AhR crosstalk. Further experiments are certainly
required to reveal the more precise mechanisms and to identify
the set of selected microbial metabolites that may account for the
observed metabolic effects. Finally, AhR resides within a family of
drugable receptors with an abundance of putative ligands, making
it an attractive target for future treatment of metabolic and other
disorders.
Table 2. List of metabolites which levels were found to be different in
AhR+/+ and AhR− /− mice fed high-fat diet
Lower in AhR− /− Higher in AhR− /−
Metabolite Correlation
coefﬁcient
Metabolite Correlation
coefﬁcient
Plasma
Methylmalonate 0.8 Tyrosine 0.9
Glucose 0.5 Creatine 0.9
3-hydroxybutyrate 0.7 Alanine 0.8
Lactate 0.8
Citrate 0.8
TMAO 0.7
Glycerol 0.7
Liver
Choline 0.7 Creatine 0.8
Formate 0.7 Glucose 0.5
3-hydroxybutyrate 0.5 Glycerol 0.5
Inosine 0.3 Alanine 0.4
Lactate 0.3
Skeletal muscle
Creatine 0.9
Taurine 0.8
Lactate 0.6
Anserine 0.9
Carnosine 0.8
Abbreviation: AhR, aryl hydrocarbon receptor; TMAO, trimethylamine N-
oxide .
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MATERIALS AND METHODS
Animals
All mice (C57Bl6/J background) were maintained on autoclaved R36
Lactamin chow (Lactamin, Stockholm, Sweden) on a 12-h light/dark cycle.
In the HFD experiment, mice received a semi-synthetic fat-rich chow R638
(40% of calories from fat) from Lantmännen, Sweden. For experiments with
bacterial ﬂora sequencing, mice received semi-synthetic F2 chow depleted
of any naturally occurring AhR ligands or F2 diet enriched in DIM, a known
AhR ligand, from postnatal day 1. Mice were assigned to receive F2 or DIM
diet at random. F2 and DIM was a generous gift from Fujii—Kurijama
(University of Tokyo, Tokyo, Japan). This food was introduced at day P1 (to
avoid any developmental problems caused by lack of AhR ligands in utero)
and mice were randomly assigned to receive F2 or DIM diets. The AhR− /−,
AhR+/+ and AhR− /+ offspring were co-housed and genotyped at the
5 weeks of age. The faecal, colonic and small intestinal material was
collected from AhR− /− and AhR+/+ mice when they reached the 8 weeks of
age. Only healthy male mice of similar age and weight were used in these
experiments after which wild type and knockout mice were randomly
assigned to different treatments. For experiments involving butyrate
Figure 4. A high-fat diet reduces nutritional stress on AhR− /− mice. Fasting glucose levels (a) and the oral glucose tolerance test (R36 AhR+/+,
n= 5 and AhR− /−, n= 4; HFD AhR+/+, n= 6 and HFD AhR− /−, n= 4) (b), left panel: glucose changes over time; right panel: area under the curve
(R36 AhR+/+, n= 5 and AhR− /−, n= 4; HFD AhR+/+, n= 6 and HFD AhR− /−, n= 4). (c) Quantitative RT-PCR results regarding the expression of
Hmgcs2, PPARα, CD36, Cpt2, Acox, Cpt1a, and G6Pase in the livers of AhR− /− and AhR+/+ mice in response to high-fat diet (HFD) (R36 AhR+/+,
n= 5 and AhR− /−, n= 4; HFD AhR+/+, n= 6 and HFD AhR− /−, n= 4). Gene expression was normalised to Hprt. *Po0.05, **Po0.01 against
AhR+/+ mice (Student’s t-test). (d) Effect of chow (R36) and HFD on plasma corticosterol levels in AhR− /− and AhR+/+ mice (R36 AhR+/+, n= 5
and AhR− /−, n= 4; HFD AhR+/+, n= 6 and HFD AhR− /−, n= 4). Corticosterol level was measured in plasma by ELISA. Bars and error bars depict
the mean± s.e.m.
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treatment, GF mice (8–10 weeks of age) were gavaged with water or
butyrate (1 g/kg body weight) and killed after 72 h of treatment.
Experimental protocol was similar to previously published treatment dose
and schedule.35
Mice were killed by cervical dislocation at the end of experiment.
All protocols involving the use of animals were approved by the Regional
Animal Research Ethical Board, Stockholm, Sweden (Stockholms
norra djurförsöksetiska nämnd), following proceedings described in EU
legislation (Council Directive 86/609/EEC). Animal husbandry was in
accordance with Karolinska Institutet guidelines and approved by the
above-mentioned ethical board (Ref: N 100/10 and 299/12). Animal
experiments adhered to 3R policy to ensure minimum numbers of animals
were used to maximise data mining.
AhR+/− mice were initially obtained from CLEA, Japan, and subsequently
crossbred to obtain AhR+/+, AhR+/− and AhR− /− genotypes. AHR+/+ and
AhR− /− mice were crossed to C57Bl/6J background. The generation of
AhR+/− has been described previously.36 Mice were maintained under SPF
conditions. Experiments with GermFree mice (GF) were performed at the
Core Facility for Germfree Research (CFGR) Karolinska Institutet, Stockholm,
Sweden.
Glucose tolerance testing and insulin measurements
Glucose tolerance tests were performed with the use of Roche Acuvue
glucometer and adequate strips. For each test, a blood drop was collected
from the tip of the tail. Blood was collected after an overnight (12 h) fasting
period, and then 15, 30, 60, 90 and 120 min after oral glucose
administration (2 g/kg body weight). Insulin levels in mice sacriﬁced after
overnight fasting (12 h), were measured in serum by ELISA (Millipore,
Billerica, MA, USA) post mortem.
Cell lines, culture conditions and treatments
The human epithelial cell line HT-29 (HBT-11) (ATCC, Rockville, MD, USA)
was cultured in RPMI 1640 media supplemented with 10% heat inactivated
foetal bovine serum (both from Invitrogen, Carlsbard, CA, USA). Cells were
maintained in a 5% CO2 humidiﬁed atmosphere at 37 °C. Cell morphogen-
esis was monitored microscopically. To prevent contact inhibition, cell
densities for each experiment did not exceed 80%. Dimethyl sulfoxide and
sodium butyrate were purchased from Sigma Aldrich (St Louis, MO, USA),
3,4-dimethoxyﬂavone was from Cayman Chemicals (Ann Arbor, MI, USA).
Inhibition experiments using AhR inhibitor 3,4-dimethoxyﬂavone (10 μmol/
l) were performed by pretreating cells with the inhibitor or vehicle
(dimethyl sulfoxide) for 1 h before stimulating cells with sodium butyrate.
Downregulation of AhR transcripts in HT-29 cells were achieved by SMART
Pool siRNA products directed against AhR (ThermoScientiﬁc). Controls
were transfected with Silencer SMART Pool Non-Targeting siRNA
(ThermoScientiﬁc, Waltham, MA, USA). Transfection was carried out
according to the manufacturer’s protocol using DharmaFECT 4 (Thermo-
Scientiﬁc) reagent (ﬁnal concentration, 0.3%), with a ﬁnal siRNA
concentration of 40 nM. Cells were treated with acetate (10 mmol/l),
propionate (5 mmol/l) or butyrate (2 mmol/l) for 24 h as previously
published.37 Control cells (NT) were treated with RPMI medium only. All
in vitro experiments were performed twice, with three biological replicates
per treatment and per experiment.
RNA extraction and RT-qPCR
RNA was isolated using the Qiagen RNeasy Mini kit according to the
manufacturer's instructions. cDNA was synthesised with SuperScript II
(Invitrogen). OligodT primers were used in the presence of RNaseOUT
reagent (Invitrogen). One microgram of RNA was used per reaction.
Complementary DNA (cDNA) was diluted 1:5 and then 1 μl was used for
each quantitative PCR (qPCR) reaction. qPCR was performed using
SYBRGreen reagent (Applied Biosystems, Carlsbard, CA, USA ) and gene-
speciﬁc primers (Supplementary Table 4). Reactions were performed with
the use of an Abi Prism 7500 (Applied Biosystems) thermal cycler.
Housekeeping genes were carefully selected for each experiment so that
their expression levels did not exhibit signiﬁcant differences between
treatments. Relative expression was calculated using the formula 2−ΔΔCt.
The average from the controls was taken as 1, and fold change for each
treatment was calculated accordingly. Each sample was tested in triplicate
for qPCR.
Western blotting
Livers were collected from fasting mice (12 h) and perfused with PBS prior
to dissection. Tissue was lysed in RIPA buffer (150 mmol/l NaCl, 50 mmol/l
Tris pH=8, 0.25 mmol/l EDTA, 1% sodium deoxycholate, 1% Triton X-100,
5 mmol/l sodium ﬂuoride; 400 mmol/l sodium vanadate; 1 mmol/l
phenylmethanesulphonylﬂuoride, 1 mmol/l dithiothreitol; 1 × Complete
Protease Inhibitors) (Roche, Mannheim, Germany). The anti-p53 antibody
was from Cell Signalling (2524), anti-mouse secondary peroxidase
conjugated antibody from DAKO A/S (P0447), and β-tubulin primary
antibody conjugated with horse-radish peroxidase from Abcam (ab21058).
Detection was conducted by chemiluminescence (BioRad, Hercules, CA,
USA). Expression of p53 was quantiﬁed against β-tubulin using Image-J
software (NIH, Bethesda, MD, USA).
Statistical analysis
Statistical analyses were performed using GraphPad Prism 6 statistical
software (La Jolla, CA, USA). For analysis with multiple groups, One-way or
Two-way analysis of variance tests were performed where relevant.
Unpaired t-test (two-tailed) was performed when observations between
two groups were compared. Po0.05 was considered statistically
signiﬁcant unless otherwise stated. Values were expressed as mean± s.e.m.
NMR metabolic proﬁling
Plasma sample preparation. Sample preparation and acquisition methods
were annotated from previously published methods.38,39 Aliquots of
mouse plasma (100 μl) were mixed with 500 μl of saline solution (0.9%
NaCl in D2O), incubated for 10 min at room temperature, and then
centrifuged at 13000 rpm for 10 min in order to remove insoluble material.
Supernatants were transferred into 5 mm NMR tubes for 1H NMR analysis.
Preparation of aqueous tissue extracts. For liver and muscle analysis, an
amount of each sample was weighed out (~200 mg liver; ~ 50 mg muscle)
and added to 1.5 ml of 50:50 water/methanol. Samples were incubated on
dry ice for a few minutes before adding 30–40 high-density 1-mm zirconia
beads. The samples were then homogenised in a bead beater (Precellys 24)
for 3 cycles (5 min each); samples were kept on dry ice between cycles.
Next, the samples were centrifuged at 13,000 r.p.m. for 10 min, and 500 μl
aliquots were transferred into a separate Eppendorf tube. The pellet was
dried and retained for the later organic extraction. Protein was precipitated
from the aqueous phase by adding 1 ml methanol, vortexing for 3 min
(Multimixer, Thomas Scientiﬁc, Swedesboro, NJ, USA, and incubating the
samples at − 20 °C overnight. Aliquots of 500 μl were then taken from the
supernatant, dried in a speed vacuum overnight at room temperature, and
subsequently frozen at − 80 °C. Before NMR acquisition, samples were
resuspended in 550 μl phosphate buffer solution (0.2 M Na2HPO4/
0.04 mol/l NaH2PO4, pH=7.4 with 0.1% sodium azide and 1 mmol/l 3-
trimethylsilyl-1-[2,2,3,3,-2H4] propionate in D2O) and transferred to a 5 mm
NMR tube for analysis.
Acquisition of 1H NMR spectra. 1H NMR spectra were acquired with a
Bruker Avance 600 MHz spectrometer (Bruker Biospin, Karlsruhe, Germany)
operating at 600.13 MHz for 1H at 300 K. It was equipped with a 5 mm
broadband inverse conﬁguration probe. Both plasma and tissue extracts
were analysed with a water-suppressed 1D NMR spectrum using the
NOESYPRESAT pulse sequence (256 transients). Irradiation of the solvent
(water) resonance was applied during presaturation delay (2.0 s) for all
spectra and for the water-suppressed 1D NMR spectra also during the
mixing time (0.1 s). The pulse sequence parameters, including the 90°
pulse (~12 μs), pulse frequency offset (~2,800 Hz), receiver gain (~200), and
pulse powers, were optimised for each sample set run. The spectral width
was 20 p.p.m. for all spectra. The NMR was processed with 1.0 Hz
exponential line broadening prior to Fourier transformation. Fourier
transformations were collected with ~ 32,000 real data points.
NMR spectral data pre-processing. Data (−1.0 to 10.0 p.p.m.) were
imported into MATLAB 7.0 software (MathWorks, Natick, MA, USA), in
which they were automatically phased, baseline corrected and referenced
to the 3-trimethylsilyl-1-[2,2,3,3,-2H4] propionate peak (0.00 p.p.m.) using
scripts written in-house. To reduce analytical variation between samples,
the residual water signal (4.67–4.98 p.p.m.) was truncated from the data
set. To enable separate normalisation to total area and use of probabilistic
quotient (median fold-change) methods, each spectrum was set to have a
unit total intensity such that each data point was expressed as a fraction
Microbiome-AhR crosstalk affects host metabolism
A Korecka et al
8
npj Bioﬁlms and Microbiomes (2016) 16014 Published in partnership with Nanyang Technological University
of the total spectral integral.40 Endogenous plasma metabolites and
metabolites extracted from liver and muscle tissues were assigned by
referring to data from published literature,41–44 as well as to in-house and
online databases.
Statistical methods and software. After the pre-processing of the NMR
data, multivariate statistical analysis was performed using both Matlab
R2013b (MathWorks, Natick, MA, USA) and SIMCA-P 13.0 software packages
(Umetrics, Umeå, Sweden). Principal components analysis (PCA) was
performed using univariate scaling. The ﬁrst two components of variation
were plotted against one another to access the inter-cohort variation
across the global metabolic proﬁle. Orthogonal partial least squares
discriminant analysis (OPLS-DA) using both univariate and mean centred
scaling was employed to identify speciﬁc metabolites pertaining to a
particular sample group.45 All OPLS models were validated using random
permutation testing of the supervised model.
High-throughput sequencing of bacterial content
DNA extraction and sequencing of 16S rRNA gene regions. DNA was
extracted from each sample using the FastDNA Spin Kit for soil (MP
Biomedicals, Leicester, UK). A modiﬁed protocol was employed as
described.46 For each sample, the V4 and V5 regions of the 16S rRNA
genes were ampliﬁed using the universal primers U515F (5′-
GTGYCAGCMGCCGCGGTA-3′) and U927R (5′-CCCGYCAATTCMTTTRAGT-3′)
. The forward fusion primer also contained the GS FLX Titanium primer A,
library Key (5′-CCATCTCATCCCTGCGTGTCTCCGACTCAG-3′), and 10-bp
multiplex identiﬁers (MID) (Roche Diagnostics, West Sussex, UK). The
reverse fusion primer included the GS FLX Titanium primer B and library
key (5’-CCTATCCCCTGTGTGCCTTGGCAGTCTCAG-3′) identiﬁers. Ampliﬁca-
tion conditions, sample pooling, preparation and sequencing on the GS
FLX titanium platform were undertaken as previously described.47
Data analysis. Raw 16S rDNA sequences were processed in QIIME48
version 1.5.0 using default parameters. Sequences were removed from the
analysis if they were o350 or 4450 base pairs, were of low quality,
contained ambiguous bases or if there were mismatches in the barcode or
forward sequencing primer. The reverse sequence primer was removed.
Remaining sequences were clustered into operational taxonomic units
using UCLUST49 at 97% sequence identity. A representative sequence for
each operational taxonomic unit was chosen and assigned taxonomy
using the RDP classiﬁer50 and Greengenes (February 2011 release).51
Sequences were rareﬁed to 3568 to remove bias caused by heterogeneity
in the number of sequences for each sample. The Mann–Whitney U-test
was used for statistical analysis of the samples.
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